PIERCE1
gene geneOn this page
Also known as MGC29761RbEST47
Summary
PIERCE1 (piercer of microtubule wall 1, HGNC:28435) is a protein-coding gene on chromosome 9q34.3, encoding Piercer of microtubule wall 1 protein (Q5BN46). Microtubule inner protein involved in the attachment of outer dynein arms (ODAs) to dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating.
Predicted to be involved in axoneme assembly; establishment of left/right asymmetry; and flagellated sperm motility. Predicted to act upstream of or within DNA damage response; cellular response to UV-C; and regulation of gene expression. Located in axonemal microtubule.
Source: NCBI Gene 138162 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 6 total
- MANE Select transcript:
NM_001048265
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28435 |
| Approved symbol | PIERCE1 |
| Name | piercer of microtubule wall 1 |
| Location | 9q34.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC29761, RbEST47 |
| Ensembl gene | ENSG00000160345 |
| Ensembl biotype | protein_coding |
| OMIM | 614502 |
| Entrez | 138162 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 8 protein_coding, 1 retained_intron
ENST00000371786, ENST00000371789, ENST00000371791, ENST00000419770, ENST00000429260, ENST00000862731, ENST00000931412, ENST00000931413, ENST00000931414
RefSeq mRNA: 2 — MANE Select: NM_001048265
NM_001048265, NM_144654
CCDS: CCDS43899, CCDS6989
Canonical transcript exons
ENST00000429260 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001051627 | 135498585 | 135498663 |
| ENSE00001793908 | 135499709 | 135499869 |
| ENSE00001918417 | 135495181 | 135495615 |
Expression profiles
Bgee: expression breadth ubiquitous, 180 present calls, max score 99.06.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.9712 / max 129.9125, expressed in 1472 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 103090 | 6.0455 | 1414 |
| 103092 | 0.8074 | 383 |
| 103093 | 0.0614 | 25 |
| 103089 | 0.0569 | 13 |
Top tissues by expression
281 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| bronchial epithelial cell | CL:0002328 | 99.06 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 98.70 | gold quality |
| right uterine tube | UBERON:0001302 | 98.68 | gold quality |
| bronchus | UBERON:0002185 | 97.72 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 97.39 | gold quality |
| left testis | UBERON:0004533 | 94.22 | gold quality |
| right testis | UBERON:0004534 | 93.87 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 92.20 | gold quality |
| testis | UBERON:0000473 | 91.70 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 90.80 | gold quality |
| caput epididymis | UBERON:0004358 | 88.93 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 88.21 | gold quality |
| adult organism | UBERON:0007023 | 87.49 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.09 | gold quality |
| right adrenal gland | UBERON:0001233 | 85.48 | gold quality |
| adenohypophysis | UBERON:0002196 | 85.33 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 85.23 | gold quality |
| left adrenal gland | UBERON:0001234 | 84.58 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 84.57 | gold quality |
| nucleus accumbens | UBERON:0001882 | 84.26 | gold quality |
| caudate nucleus | UBERON:0001873 | 84.01 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 83.90 | gold quality |
| pituitary gland | UBERON:0000007 | 83.43 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 83.23 | gold quality |
| adrenal cortex | UBERON:0001235 | 82.61 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 82.38 | gold quality |
| cingulate cortex | UBERON:0003027 | 82.33 | gold quality |
| hypothalamus | UBERON:0001898 | 81.71 | gold quality |
| adrenal gland | UBERON:0002369 | 81.35 | gold quality |
| right frontal lobe | UBERON:0002810 | 81.25 | gold quality |
Single-cell (SCXA)
Detected in 7 experiment(s), a significant marker in 7.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-CURD-114 | yes | 64.26 |
| E-HCAD-1 | yes | 32.70 |
| E-MTAB-10287 | yes | 28.18 |
| E-MTAB-6701 | yes | 15.70 |
| E-GEOD-130148 | yes | 13.13 |
| E-MTAB-9388 | yes | 6.89 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): TP53
miRNA regulators (miRDB)
29 targeting PIERCE1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6748-5P | 100.00 | 65.81 | 1057 |
| HSA-MIR-3689D | 100.00 | 66.14 | 1181 |
| HSA-MIR-6851-5P | 100.00 | 65.63 | 1294 |
| HSA-MIR-432-3P | 100.00 | 67.86 | 705 |
| HSA-MIR-1193 | 100.00 | 65.93 | 529 |
| HSA-MIR-448 | 99.79 | 72.37 | 2103 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-3685 | 99.62 | 68.83 | 1621 |
| HSA-MIR-363-5P | 99.46 | 64.51 | 1015 |
| HSA-MIR-4504 | 99.10 | 69.14 | 1328 |
| HSA-MIR-7854-3P | 99.08 | 66.26 | 1117 |
| HSA-MIR-4651 | 99.06 | 67.57 | 2002 |
| HSA-MIR-608 | 98.93 | 67.83 | 2013 |
| HSA-MIR-4501 | 98.72 | 67.19 | 921 |
| HSA-MIR-7155-5P | 98.65 | 66.14 | 1290 |
| HSA-MIR-3613-5P | 98.40 | 68.91 | 604 |
| HSA-MIR-4664-5P | 98.17 | 65.07 | 1020 |
| HSA-MIR-6819-5P | 97.96 | 66.59 | 1071 |
| HSA-MIR-6737-5P | 97.75 | 66.54 | 1044 |
| HSA-MIR-3190-3P | 97.61 | 66.95 | 1406 |
| HSA-MIR-6812-5P | 97.56 | 65.39 | 1059 |
| HSA-MIR-342-5P | 97.25 | 64.10 | 817 |
| HSA-MIR-582-3P | 96.69 | 67.38 | 1019 |
| HSA-MIR-12128 | 96.67 | 66.98 | 1471 |
| HSA-MIR-6747-5P | 96.17 | 64.99 | 743 |
| HSA-MIR-576-3P | 96.14 | 65.63 | 773 |
| HSA-MIR-6735-3P | 96.10 | 63.81 | 600 |
| HSA-MIR-6767-5P | 90.00 | 62.41 | 97 |
| HSA-MIR-4750-5P | 80.79 | 59.79 | 18 |
Literature-anchored findings (GeneRIF, showing 1)
- Divergence of the PIERCE1 expression between mice and humans as a p53 target gene. (PMID:32745107)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | pierce1 | ENSDARG00000058940 |
| mus_musculus | Pierce1 | ENSMUSG00000026831 |
| rattus_norvegicus | Pierce1 | ENSRNOG00000010152 |
| drosophila_melanogaster | CG34107 | FBGN0083943 |
Paralogs (1): PIERCE2 (ENSG00000261652)
Protein
Protein identifiers
Piercer of microtubule wall 1 protein — Q5BN46 (reviewed: Q5BN46)
Alternative names: UPF0691 protein C9orf116, p53-induced expression in RB-null cells protein 1
All UniProt accessions (2): Q5BN46, H0Y549
UniProt curated annotations — full annotation on UniProt →
Function. Microtubule inner protein involved in the attachment of outer dynein arms (ODAs) to dynein-decorated doublet microtubules (DMTs) in cilia axoneme, which is required for motile cilia beating. Functions at the initial step of left-right asymmetry specification of the visceral organs.
Subunit / interactions. Microtubule inner protein component of sperm flagellar doublet microtubules. Interacts with CFAP53, ODAD1 and ODAD3; the interactions link the outer dynein arms docking complex (ODA-DC) to the internal microtubule inner proteins (MIP) in cilium axoneme.
Subcellular location. Cytoplasm. Cytoskeleton. Cilium axoneme. Flagellum axoneme.
Tissue specificity. Expressed in airway epithelial cells.
Similarity. Belongs to the PIERCE1 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q5BN46-1 | 1 | yes |
| Q5BN46-2 | 2 |
RefSeq proteins (2): NP_001041730, NP_653255 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR026507 | PIRC1/2 | Family |
Pfam: PF14892
UniProt features (4 total): splice variant 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7UNG | ELECTRON MICROSCOPY | 3.6 |
| 8J07 | ELECTRON MICROSCOPY | 4.1 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5BN46-F1 | 77.39 | 0.35 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 123 (showing top):
GSE45365_NK_CELL_VS_CD8A_DC_DN, GOBP_RESPONSE_TO_UV_C, GOBP_CELLULAR_RESPONSE_TO_UV, GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS, GOBP_SPECIFICATION_OF_SYMMETRY, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, SMID_BREAST_CANCER_LUMINAL_B_UP, GOBP_CILIUM_ORGANIZATION, GOBP_CILIUM_MOVEMENT, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_RESPONSE_TO_UV, GOBP_DNA_DAMAGE_RESPONSE, GOBP_RESPONSE_TO_RADIATION, GOBP_ORGANELLE_ASSEMBLY, GOBP_MICROTUBULE_BUNDLE_FORMATION
GO Biological Process (8): cilium movement (GO:0003341), DNA damage response (GO:0006974), determination of left/right symmetry (GO:0007368), regulation of gene expression (GO:0010468), flagellated sperm motility (GO:0030317), axoneme assembly (GO:0035082), establishment of left/right asymmetry (GO:0061966), cellular response to UV-C (GO:0071494)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (9): nucleus (GO:0005634), cytoplasm (GO:0005737), axonemal microtubule (GO:0005879), sperm flagellum (GO:0036126), axonemal A tubule inner sheath (GO:0160111), cytoskeleton (GO:0005856), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| microtubule-based movement | 1 |
| cellular response to stress | 1 |
| determination of bilateral symmetry | 1 |
| left/right pattern formation | 1 |
| gene expression | 1 |
| regulation of macromolecule biosynthetic process | 1 |
| cilium-dependent cell motility | 1 |
| cilium movement involved in cell motility | 1 |
| sperm motility | 1 |
| microtubule bundle formation | 1 |
| cellular component assembly | 1 |
| cilium assembly | 1 |
| determination of left/right symmetry | 1 |
| response to UV-C | 1 |
| cellular response to UV | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular anatomical structure | 1 |
| cytoplasmic microtubule | 1 |
| axoneme | 1 |
| 9+2 motile cilium | 1 |
| A axonemal microtubule | 1 |
| axonemal microtubule doublet inner sheath | 1 |
| intracellular membraneless organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
| cilium | 1 |
Protein interactions and networks
STRING
1416 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PIERCE1 | CFAP90 | A4QMS7 | 727 |
| PIERCE1 | CFAP96 | A7E2U8 | 593 |
| PIERCE1 | CFAP184 | Q2M329 | 580 |
| PIERCE1 | CLXN | Q9HAE3 | 575 |
| PIERCE1 | SOWAHA | Q2M3V2 | 549 |
| PIERCE1 | IQUB | Q8NA54 | 544 |
| PIERCE1 | TEKTIP1 | A6NCJ1 | 506 |
| PIERCE1 | ARMC3 | Q5W041 | 493 |
| PIERCE1 | KRT80 | Q6KB66 | 447 |
| PIERCE1 | PIERCE2 | H3BRN8 | 447 |
| PIERCE1 | VSTM2L | Q96N03 | 443 |
| PIERCE1 | DAND5 | Q8N907 | 438 |
| PIERCE1 | IFT57 | Q9NWB7 | 432 |
| PIERCE1 | CCDC170 | Q8IYT3 | 377 |
| PIERCE1 | IQCF3 | P0C7M6 | 376 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PIERCE1 | FHL3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FHL3 | PIERCE1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (3): C9orf116 (Two-hybrid), HSPA8 (Affinity Capture-MS), FHL3 (Two-hybrid)
ESM2 similar proteins: A0A1B0GTD5, A0A1B0GUX0, A0A3Q1MT14, A4D263, A6NL82, A6QQL5, A8QW39, B0UXH9, B5X5D0, B9EJX3, E1B9R1, F1MMV1, Q148A4, Q1JPL0, Q2T9T0, Q32KQ1, Q32L72, Q32L77, Q32P67, Q3V0J4, Q5BN46, Q5NC57, Q5NC83, Q5SPV6, Q5SS90, Q5SVJ3, Q5VTT2, Q5VZQ5, Q66HC0, Q66HR9, Q6AYM0, Q6NXP0, Q6P3G4, Q6ZVS7, Q80X60, Q8CDT5, Q8CDU5, Q8N5S3, Q8N7U6, Q8N865
Diamond homologs: B0UXH9, B5X5D0, Q32P67, Q5BN45, Q5BN46
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
6 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
756 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 9:135495612:CTTT:C | acceptor_gain | 1.0000 |
| 9:135498583:A:AC | donor_gain | 1.0000 |
| 9:135498584:C:CC | donor_gain | 1.0000 |
| 9:135499524:T:TA | donor_gain | 1.0000 |
| 9:135495613:TTT:T | acceptor_gain | 0.9900 |
| 9:135495614:TT:T | acceptor_gain | 0.9900 |
| 9:135495615:TC:T | acceptor_loss | 0.9900 |
| 9:135495616:C:CC | acceptor_gain | 0.9900 |
| 9:135495616:CT:C | acceptor_loss | 0.9900 |
| 9:135498584:CAGG:C | donor_gain | 0.9900 |
| 9:135499525:C:A | donor_gain | 0.9900 |
| 9:135499561:A:AC | donor_gain | 0.9900 |
| 9:135499562:C:CC | donor_gain | 0.9900 |
| 9:135499744:G:A | donor_gain | 0.9900 |
| 9:135500112:G:GT | donor_gain | 0.9900 |
| 9:135500171:GGGTT:G | donor_gain | 0.9900 |
| 9:135500172:GGTT:G | donor_gain | 0.9900 |
| 9:135500238:G:T | donor_gain | 0.9900 |
| 9:135501121:CCGG:C | donor_loss | 0.9900 |
| 9:135501125:T:A | donor_loss | 0.9900 |
| 9:135496407:T:A | donor_gain | 0.9800 |
| 9:135498583:ACAGG:A | donor_gain | 0.9800 |
| 9:135498584:CAGGC:C | donor_gain | 0.9800 |
| 9:135498664:C:CC | acceptor_gain | 0.9800 |
| 9:135499702:T:TA | donor_gain | 0.9800 |
| 9:135499723:C:CT | donor_gain | 0.9800 |
| 9:135500168:ACGGG:A | donor_gain | 0.9800 |
| 9:135500202:C:T | donor_gain | 0.9800 |
| 9:135500835:G:T | donor_gain | 0.9800 |
| 9:135501124:G:GG | donor_gain | 0.9800 |
AlphaMissense
901 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 9:135499738:G:C | F38L | 0.985 |
| 9:135499738:G:T | F38L | 0.985 |
| 9:135499740:A:G | F38L | 0.985 |
| 9:135499739:A:G | F38S | 0.964 |
| 9:135495607:A:C | F77L | 0.961 |
| 9:135495607:A:T | F77L | 0.961 |
| 9:135495609:A:G | F77L | 0.961 |
| 9:135495469:G:C | F123L | 0.959 |
| 9:135495469:G:T | F123L | 0.959 |
| 9:135495471:A:G | F123L | 0.959 |
| 9:135498616:C:T | G64E | 0.959 |
| 9:135495586:A:C | F84L | 0.957 |
| 9:135495586:A:T | F84L | 0.957 |
| 9:135495588:A:G | F84L | 0.957 |
| 9:135498604:G:T | P68H | 0.951 |
| 9:135498630:A:C | S59R | 0.946 |
| 9:135498630:A:T | S59R | 0.946 |
| 9:135498632:T:G | S59R | 0.946 |
| 9:135499720:G:C | F44L | 0.944 |
| 9:135499720:G:T | F44L | 0.944 |
| 9:135499722:A:G | F44L | 0.944 |
| 9:135495460:A:C | S126R | 0.943 |
| 9:135495460:A:T | S126R | 0.943 |
| 9:135495462:T:G | S126R | 0.943 |
| 9:135495538:A:C | N100K | 0.942 |
| 9:135495538:A:T | N100K | 0.942 |
| 9:135498617:C:A | G64W | 0.942 |
| 9:135498641:A:C | Y56D | 0.938 |
| 9:135499741:C:A | R37S | 0.938 |
| 9:135499741:C:G | R37S | 0.938 |
dbSNP variants (sampled 300 via entrez): RS1000080091 (9:135497044 G>A,C,T), RS1000785408 (9:135499272 G>A), RS1001673151 (9:135499651 C>T), RS1001704060 (9:135499190 C>T), RS1001821806 (9:135495548 T>C), RS1002053474 (9:135500003 C>A,G,T), RS1002312299 (9:135494953 T>C), RS1002708703 (9:135497857 G>A,C), RS1002828368 (9:135496914 A>G), RS1003920820 (9:135500090 G>A,T), RS1003961470 (9:135497330 T>C), RS1004295471 (9:135497524 A>G), RS1006232056 (9:135501050 G>A), RS1006263169 (9:135501288 A>C), RS1006411223 (9:135501616 C>A,G,T)
Disease associations
OMIM: gene MIM:614502 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009391_1180 | Metabolite levels | 7.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0010454 | adenosine monophosphate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects expression, increases expression, increases methylation | 5 |
| Air Pollutants | decreases expression, increases abundance, increases expression | 2 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 2 |
| Smoke | increases expression, decreases expression, increases abundance | 2 |
| Tobacco Smoke Pollution | affects expression, decreases expression | 2 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Leflunomide | decreases expression | 1 |
| Carbamazepine | affects expression | 1 |
| Cisplatin | decreases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ethinyl Estradiol | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Zidovudine | decreases expression, affects cotreatment | 1 |
| Cyclosporine | decreases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.